TABLE 2A.
Results of stepwise linear regression analyses for subscales of the Positive and Negative Syndrome Scale.
| Adj. R2 = 0.816; P (model) = 2⋅10−12 | |||||||||
| b (PANSS_pos change) | b SE | P-value | –95.00% CI | +95.00% CI | β | β SE | –95.00% CI | +95.00% CI | |
| Intercept | -2.113 | 1.429 | 0.15 | -5.024 | 0.797 | ||||
| C4 complement | -10.914 | 4.179 | 0.01* | -19.427 | -2.401 | -0.199 | 0.076 | -0.353 | -0.044 |
| Chlorpromazine | -0.012 | 0.004 | 0.009* | -0.021 | -0.003 | -0.231 | 0.084 | -0.402 | -0.062 |
| PANSS_pos | 0.847 | 0.070 | 2⋅10–13* | 0.703 | 0.991 | 1.033 | 0.086 | 0.857 | 1.208 |
Modeling of PANSS_pos scale change after 12 weeks of pharmacological treatment.
*Statistically significant at α = 0.05.
All parameters present values at the time of admission.